Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.”
EClinicalMedicine
; 51, 2022.
Article
in English
| EuropePMC | ID: covidwho-2033946
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Type of study:
Experimental Studies
/
Randomized controlled trials
Language:
English
Journal:
EClinicalMedicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS